Ameritas Advisory Services LLC Buys Shares of 371 VanEck Biotech ETF $BBH

Ameritas Advisory Services LLC bought a new stake in VanEck Biotech ETF (NASDAQ:BBH) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 371 shares of the company’s stock, valued at approximately $57,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in BBH. Flagship Harbor Advisors LLC raised its position in VanEck Biotech ETF by 9.8% in the first quarter. Flagship Harbor Advisors LLC now owns 2,179 shares of the company’s stock valued at $343,000 after purchasing an additional 195 shares during the period. Continuum Advisory LLC raised its position in VanEck Biotech ETF by 26.1% in the first quarter. Continuum Advisory LLC now owns 1,304 shares of the company’s stock valued at $205,000 after purchasing an additional 270 shares during the period. Wealthfront Advisers LLC raised its position in VanEck Biotech ETF by 25.1% in the first quarter. Wealthfront Advisers LLC now owns 7,252 shares of the company’s stock valued at $1,141,000 after purchasing an additional 1,455 shares during the period. Cetera Investment Advisers raised its position in VanEck Biotech ETF by 15.8% in the first quarter. Cetera Investment Advisers now owns 3,094 shares of the company’s stock valued at $487,000 after purchasing an additional 423 shares during the period. Finally, Altfest L J & Co. Inc. raised its position in VanEck Biotech ETF by 15.1% in the first quarter. Altfest L J & Co. Inc. now owns 7,661 shares of the company’s stock valued at $1,205,000 after purchasing an additional 1,007 shares during the period. Hedge funds and other institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Price Performance

Shares of NASDAQ BBH opened at $172.13 on Monday. VanEck Biotech ETF has a 52-week low of $135.34 and a 52-week high of $178.95. The business’s 50 day moving average is $166.39 and its two-hundred day moving average is $156.85.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.